Allen Tracy L, Tatli Yusuf, Lutz Gregory E
Physiatry Department, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA.
Spine J. 2009 May;9(5):387-95. doi: 10.1016/j.spinee.2008.08.008. Epub 2008 Sep 21.
Lumbar zygapophyseal joint (Z-joint) synovial cysts can cause low back pain (LBP), spinal stenosis, and lower extremity radiculopathy. In the literature, there are several minimally invasive techniques described with mixed results. Typical recommended treatment is surgical resection of the cyst. Currently, there is little information available concerning the efficacy and outcome with treatment of Z-joint synovial cyst by percutaneous, fluoroscopic, contrast-enhanced distention, and rupture.
To evaluate the therapeutic value and safety of Z-joint cyst rupture in symptomatic patients.
STUDY DESIGN/SETTING: Retrospective cohort study in an academic outpatient physiatric spine practice.
Thirty-two patients with moderate-to-severe LBP and leg pain (18 women and 14 men with an age range of 46-86 y; mean age, 66 y) with an average preprocedure symptom duration of 5 months. The patient's clinical symptoms correlated with magnetic resonance imaging studies documenting the presence of a synovial cyst at the corresponding level and side of symptoms. Patients had at least 6 months follow-up (range, 6-24).
Numerical Pain Rating Scale, Roland-Morris Disability Questionnaire, North American Spine Society four-point patient satisfaction survey, recurrence of synovial cyst requiring repeat rupture, and need for surgical intervention.
Patients with symptomatic lumbar Z-joint synovial cyst were identified and their charts were reviewed. Patients included in the study either had symptomatic lumbar LBP or LBP with associated lower extremity radiculopathy. All patients in the study had magnetic resonance imaging's documenting Z-joint synovial cyst that corresponded with the patients' clinical symptoms. All patients received fluoroscopically guided, contrast-enhanced, percutaneous facet cyst distention and rupture followed by an intra-articular facet joint injection of 1 cc kenalog and 1 cc of 1% lidocaine. Seventeen of the patients also received a transforaminal epidural steroid injection just before facet cyst rupture. Telephone follow-up was conducted on all patients.
Excellent long-term (average follow-up 1 y; range, 6-24 mo) pain relief was achieved in 23 (72%) of 32 patients undergoing facet cyst rupture. Twelve patients (37.5%) had synovial cyst recurrence and 11 chose to undergo repeat rupture, which resulted in 5 patients (45%) obtaining complete relief of symptoms and 6 patients (55%) requiring surgical intervention for cyst removal. Fisher exact test demonstrated that all patients who did not have a cyst recurrence were a success and obtained complete relief of symptoms (p<.0002). Patients who underwent a repeat rupture had a 50% chance of a successful outcome. There was no statistical significance between a successful outcome and level of facet cyst rupture, the presence of spondylolisthesis, sex, age, or having a transforaminal epidural steroid injection at the time of the procedure. Wilcoxon signed-rank test demonstrated that the difference in Numerical Pain Rating Scale and Roland-Morris Disability Questionnaire scores before and after the procedure was statistically significant (p<.0001). No complications were reported.
Fluoroscopic percutaneous Z-joint cyst rupture appears to be a safe and effective minimally invasive treatment option. This procedure should be considered before surgical intervention.
腰椎关节突关节(Z关节)滑膜囊肿可导致腰痛(LBP)、椎管狭窄和下肢神经根病。文献中描述了几种微创技术,结果不一。典型的推荐治疗方法是囊肿手术切除。目前,关于经皮、透视引导、造影剂增强扩张和破裂治疗Z关节滑膜囊肿的疗效和结果的信息很少。
评估有症状患者Z关节囊肿破裂的治疗价值和安全性。
研究设计/地点:在学术性门诊物理医学脊柱诊所进行的回顾性队列研究。
32例中重度腰痛和腿痛患者(18例女性,14例男性,年龄范围46 - 86岁;平均年龄66岁),术前平均症状持续时间5个月。患者的临床症状与磁共振成像研究结果相关,该研究记录了相应节段和症状侧存在滑膜囊肿。患者至少随访6个月(范围6 - 24个月)。
数字疼痛评分量表、罗兰-莫里斯残疾问卷、北美脊柱协会四点患者满意度调查、需要重复破裂的滑膜囊肿复发情况以及手术干预需求。
确定有症状的腰椎Z关节滑膜囊肿患者并查阅其病历。纳入研究的患者要么有症状性腰椎LBP,要么有LBP伴相关下肢神经根病。研究中的所有患者均有磁共振成像记录与患者临床症状相对应的Z关节滑膜囊肿。所有患者均接受透视引导下、造影剂增强的经皮小关节囊肿扩张和破裂,随后在关节内小关节注射1cc曲安奈德和1cc 1%利多卡因。17例患者在小关节囊肿破裂前还接受了经椎间孔硬膜外类固醇注射。对所有患者进行电话随访。
32例行小关节囊肿破裂的患者中,23例(72%)实现了长期(平均随访1年;范围6 - 24个月)的疼痛缓解。12例患者(37.5%)出现滑膜囊肿复发,11例选择再次破裂,其中5例(45%)症状完全缓解,6例(55%)需要手术切除囊肿。费舍尔精确检验表明,所有未出现囊肿复发的患者均成功且症状完全缓解(p <.0002)。再次破裂的患者有50%的成功几率。成功结果与小关节囊肿破裂水平、椎体滑脱的存在、性别、年龄或手术时是否接受经椎间孔硬膜外类固醇注射之间无统计学意义。威尔科克森符号秩检验表明,术前和术后数字疼痛评分量表和罗兰-莫里斯残疾问卷得分的差异具有统计学意义(p <.0001)。未报告并发症。
透视引导下经皮Z关节囊肿破裂似乎是一种安全有效的微创治疗选择。在手术干预前应考虑该方法。